Evidence map›Paper›PMID 34206290›Full record

ArticleChildren (Basel, Switzerland)2021

Multidisciplinary Approach for Hypothalamic Obesity in Children and Adolescents: A Preliminary Study.

Daniele Tessaris, Patrizia Matarazzo, Gerdi Tuli, Antonella Tuscano, Ivana Rabbone, Alessandra Spinardi, Antonella Lezo, Giorgia Fenocchio, Raffaele Buganza, Luisa de Sanctis

Open access · goldAbstract read
In one paragraph

Article in Children (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Approach to the patient with acquired hypothalamic syndrome.The Journal of clinical endocrinology and metabolism · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Approach to the Patient With Hypothalamic Obesity.The Journal of clinical endocrinology and metabolism · 2023
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Daniele TessarisPediatric Endocrinology Unit, Regina Margherita Children's Hospital, University of Turin, 10126 Turin, Italy.
Patrizia MatarazzoPediatric Endocrinology Unit, Regina Margherita Children's Hospital, University of Turin, 10126 Turin, Italy.
Gerdi TuliPediatric Endocrinology Unit, Regina Margherita Children's Hospital, University of Turin, 10126 Turin, Italy.
Antonella TuscanoPostgraduation School of Pediatrics, University of Turin, 10126 Turin, Italy.
Ivana RabbonePediatric Endocrinology Unit, Regina Margherita Children's Hospital, University of Turin, 10126 Turin, Italy.
Alessandra SpinardiSUISM, University of Turin, 10126 Turin, Italy.
Antonella LezoDietetic and Clinical Nutrition Unit, Regina Margherita Children's Hospital, 10126 Turin, Italy.
Giorgia FenocchioClinical Psychology, Regina Margherita Children's Hospital, 10126 Turin, Italy.
Raffaele BuganzaPediatric Endocrinology Unit, Regina Margherita Children's Hospital, University of Turin, 10126 Turin, Italy.
Luisa de SanctisPediatric Endocrinology Unit, Regina Margherita Children's Hospital, University of Turin, 10126 Turin, Italy.
Ospedale Regina Margherita · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypothalamic obesity (HO) is delineated by an inexorable weight gain in subjects with hypothalamic disorder (congenital or acquired). The aim of the present study was to evaluate the effect of a multidisciplinary approach on weight trend and metabolic outcome in children and adolescents with hypothalamic disease who were overweight or obese. Thirteen patients (aged 8.1-16.1 years) received a personalized diet, accelerometer-based activity monitoring, and psychological assessment. Height, weight, body mass index (BMI), and serum metabolic parameters were assessed at baseline (T0) and after six months (T1). Metformin was introduced at T1 in four subjects who were then re-evaluated after six months (T2). At T1, weight gain was significantly reduced compared with T0 (0.29 ± 0.79 kg/month vs. 0.84 ± 0.55 kg/month,

Indexed as

BMIhypothalamic obesitymetforminweight gain

Identifiers

PMID34206290
PMCPMC8304472
OpenAlexW3177030786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.